...
首页> 外文期刊>Japanese Journal of Pharmacology >Facilitatory and Inhibitory Effects of Harmaline on the Tryptophan-Induced 5-Hydroxytryptamine Syndrome and Body Temperature Changes in Pargyline-Pretreated Rats
【24h】

Facilitatory and Inhibitory Effects of Harmaline on the Tryptophan-Induced 5-Hydroxytryptamine Syndrome and Body Temperature Changes in Pargyline-Pretreated Rats

机译:Harmaline对色氨酸诱导的Pargyline预处理大鼠色氨酸诱导的5-羟色胺综合征和体温变化的促进和抑制作用

获取原文
           

摘要

References(33) Cited-By(5) The effects of harmaline on tryptophan-induced 5-hydroxytryptamine (5-HT) syndrome and body temperature changes in pargyline-pretreated rats were investigated. When administered i.p. 60 min after pargyline treatment (50 mg/kg, i.p.), tryptophan, at 100 mg/kg but not 10 mg/kg, induced the 5-HT syndrome. Tryptophan at 100 mg/kg also produced hypothermia followed by hyperthermia in pargyline-pretreated rats. Administration of harmaline (10 mg/kg, i.p.) 30 min after pargyline not only potentiated the 100 mg/kg tryptophan-induced 5-HT syndrome and body temperature changes, but also produced the syndrome following administration of 10 mg/kg tryptophan in pargyline-pretreated rats. In contrast, when administered 30 min before pargyline, 10 mg/kg harmaline completely suppressed the syndrome and body temperature changes caused by 100 mg/kg tryptophan. Tryptophan (100 mg/kg, i.p.) administration significantly increased 5-HT levels and decreased 5-hydroxyindole acetic acid levels and 5-HT turnover in the brain of pargyline-pretreated rats. Harmaline administration 30 min after pargyline did not significantly affect the tryptophan-induced changes in 5-HT Ievels and 5-HT turnover, whereas when administered 30 min before pargyline, harmaline significantly blocked the effect of tryptophan. These results suggest that mechanisms underlying the inhibitory action of harmaline on the tryptophan-induced 5-HT syndrome and body temperature changes in pargyline-pretreated rats differ from those by which harmaline potentiates the effects of tryptophan.
机译:参考文献(33)引用了(5)研究了harmaline对色氨酸诱导的5-羟色胺(5-HT)综合征和体温变化对pargyline预处理的大鼠的影响。腹膜内注射时Pargyline治疗后60分钟(50 mg / kg,腹膜内),100 mg / kg而不是10 mg / kg的色氨酸诱发5-HT综合征。在经Pargyline预处理的大鼠中,100 mg / kg的色氨酸也会产生体温过低,然后产生体温过高。注射Pargyline 30分钟后给予harmaline(10 mg / kg,ip)不仅增强了100 mg / kg色氨酸诱发的5-HT综合征和体温变化,而且在Pargyline中给药10 mg / kg色氨酸后也产生该综合征-预处理的大鼠。相比之下,当在Pargyline前30分钟给药时,10 mg / kg的harmaline可完全抑制100 mg / kg色氨酸引起的综合征和体温变化。给予色氨酸(100 mg / kg,腹腔注射)可以显着提高经Pargyline预处理的大鼠的大脑中的5-HT水平,并降低5-羟吲哚乙酸水平和5-HT转换。注射精氨酸后30分钟的Harmaline给药不会显着影响色氨酸诱导的5-HT Ievels和5-HT周转率的变化,而当在注射精氨酸之前30分钟给药时,harmaline可显着阻断色氨酸的作用。这些结果表明,harmaline对色氨酸诱导的5-HT综合征的抑制作用和在经过Pargyline预处理的大鼠体内的体温变化的潜在机制与harmaline增强色氨酸的作用的机制不同。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号